Other RAS/RAF/MEK/ERK Mutated Tumors
1 clinical trials · Condition
◉ Watch Other RAS/RAF/MEK/ERK Mutated Tumors
| Record | Firm | Date |
|---|---|---|
| A Study to Evaluate the Safety, Tolerability and Pharmacokinetics of HH2710 in Patient With Advanced Tumors (NCT04198818) | Haihe Biopharma Co., Ltd. | 2020-01-07 |
Track Other RAS/RAF/MEK/ERK Mutated Tumors automatically
Every clearance here is in the API, with alerts when new ones post.